Pathogen-Reduced Human Plasma from Canada
Human plasma treated with amotosalen/UVA light to inactivate viruses, bacteria, and parasites while preserving therapeutic proteins. Used for transfusion in immunocompromised patients. HTS 3002.12.00.10 covers this modified human blood plasma.
Duty Rate — Canada → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Submit INTERCEPT or similar pathogen reduction system validation data to FDA/CBP
• Label with specific inactivation log reduction claims (e.g
• >5 log HIV) for classification support